MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202421085334 A) filed by Alkem Laboratories Limited on November 07, 2024, for Pharmaceutical Composition Comprising Semaglutide.
Inventors include Sehgal, Ashish; Anand, Chinmay; Bera, Piumitali; Kawalkar, Nitin; and Kushwaha, Shailendra Singh.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: ABSTRACT OF THE INVENTION Pharmaceutical composition comprising Semaglutide The present invention relates to pharmaceutical compositions comprising glucagon-like peptide-1 (GLP-1) receptor agonist and a permeation enhancer. In particular, the present invention provides stabilized pharmaceutical compositions com...